CAS: 2260886-64-2
N-(trans-4-(3-(2-Chlorophenyl)-7-((3-methyl-4-(4-methylpiperazin-1-yl)phenyl)amino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)cyclohexyl)propionamide
CAS:2260886-64-2
Fórmula:
C33H41ClN8O2
Pureza:
97%
Peso molecular:
617.1840
Ref: IN-DA01KL3B
| 1mg | 119,00 € | ||
| 5mg | 173,00 € | ||
| 10mg | 280,00 € | ||
| 25mg | 531,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
JND3229
CAS:2260886-64-2
JND3229 is a synthetic, non-small-cell EGFR inhibitor that targets the kinase domain of EGFR. It …
Fórmula:
C33H41ClN8O2
Pureza:
Min. 95%
Peso molecular:
617.2 g/mol
Ref: 3D-KQD88664
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
JND3229
CAS:2260886-64-2
JND3229 inhibits EGFRC797S; IC50: 5.8-30.5 nM; halts cell growth; effective in non-small cell lung cancer …
Fórmula:
C33H41ClN8O2
Pureza:
97.35%
Forma y color:
Solid
Peso molecular:
617.18
Ref: TM-T15615
| 1mg | 60,00 € | ||
| 5mg | 126,00 € | ||
| 10mg | 186,00 € | ||
| 1mL*10mM (DMSO) | 167,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Febrero de 2025
